233 related articles for article (PubMed ID: 10950936)
1. Functional characterization of the novel mutation IVS 8 (-11delC) (-14T>A) in the intron 8 of the glucocerebrosidase gene of two Italian siblings with Gaucher disease type I.
Romano M; Danek GM; Baralle FE; Mazzotti R; Filocamo M
Blood Cells Mol Dis; 2000 Jun; 26(3):171-6. PubMed ID: 10950936
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two novel GBA mutations causing Gaucher disease that lead to aberrant RNA species by using functional splicing assays.
Dominissini S; Buratti E; Bembi B; Baralle M; Pittis MG
Hum Mutat; 2006 Jan; 27(1):119. PubMed ID: 16329099
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian gaucher patients.
Filocamo M; Mazzotti R; Stroppiano M; Seri M; Giona F; Parenti G; Regis S; Corsolini F; Zoboli S; Gatti R
Hum Mutat; 2002 Sep; 20(3):234-5. PubMed ID: 12204005
[TBL] [Abstract][Full Text] [Related]
4. A new gene-pseudogene fusion allele due to a recombination in intron 2 of the glucocerebrosidase gene causes Gaucher disease.
Cormand B; Díaz A; Grinberg D; Chabás A; Vilageliu L
Blood Cells Mol Dis; 2000 Oct; 26(5):409-16. PubMed ID: 11112377
[TBL] [Abstract][Full Text] [Related]
5. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
[TBL] [Abstract][Full Text] [Related]
6. Gaucher disease: functional expression of the normal glucocerebrosidase and Gaucher T1366G and G1604A alleles in Baculovirus-transfected Spodoptera frugiperda cells.
Choy FY; Wei C; Levin D
Am J Med Genet; 1996 Oct; 65(3):184-9. PubMed ID: 9240741
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of Gaucher disease in a Vietnamese-Czechoslovak patient with high residual glucocerebrosidase activity.
Choy FY; Woo M; Der Kaloustian VM
Am J Med Genet; 1991 Jun; 39(4):466-71. PubMed ID: 1877626
[TBL] [Abstract][Full Text] [Related]
8. A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease.
Di Leo E; Panico F; Tarugi P; Battisti C; Federico A; Calandra S
Hum Mutat; 2004 Nov; 24(5):440. PubMed ID: 15459971
[TBL] [Abstract][Full Text] [Related]
9. Cryptic splice site in the complementary DNA of glucocerebrosidase causes inefficient expression.
Bukovac SW; Bagshaw RD; Rigat BA; Callahan JW; Clarke JT; Mahuran DJ
Anal Biochem; 2008 Oct; 381(2):276-8. PubMed ID: 18619939
[TBL] [Abstract][Full Text] [Related]
10. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.
Klima H; Ullrich K; Aslanidis C; Fehringer P; Lackner KJ; Schmitz G
J Clin Invest; 1993 Dec; 92(6):2713-8. PubMed ID: 8254026
[TBL] [Abstract][Full Text] [Related]
11. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
12. Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations.
Pomponio RJ; Cabrera-Salazar MA; Echeverri OY; Miller G; Barrera LA
Mol Genet Metab; 2005 Dec; 86(4):466-72. PubMed ID: 16185907
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
[TBL] [Abstract][Full Text] [Related]
14. 55-base pair deletion in certain patients with Gaucher disease complicates screening for common Gaucher alleles.
Tayebi N; Stern H; Dymarskaia I; Herman J; Sidransky E
Am J Med Genet; 1996 Dec; 66(3):316-9. PubMed ID: 8985494
[TBL] [Abstract][Full Text] [Related]
15. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
[TBL] [Abstract][Full Text] [Related]
16. N34S mutation in the SPINK1 gene is not associated with alternative splicing.
Masamune A; Kume K; Takagi Y; Kikuta K; Satoh K; Satoh A; Shimosegawa T
Pancreas; 2007 May; 34(4):423-8. PubMed ID: 17446841
[TBL] [Abstract][Full Text] [Related]
17. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
18. A novel RNA splicing mutation in Japanese patients with Wilson disease.
Shimizu N; Kawase C; Nakazono H; Hemmi H; Shimatake H; Aoki T
Biochem Biophys Res Commun; 1995 Dec; 217(1):16-20. PubMed ID: 8526905
[TBL] [Abstract][Full Text] [Related]
19. DNA analysis of an uncommon missense mutation in a Gaucher disease patient of Jewish-Polish-Russian descent.
Choy FY; Wei C; Applegarth DA; McGillivray BC
Am J Med Genet; 1994 Jun; 51(2):156-60. PubMed ID: 7916532
[TBL] [Abstract][Full Text] [Related]
20. Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.
Yagi M; Takeshima Y; Wada H; Nakamura H; Matsuo M
Hum Genet; 2003 Feb; 112(2):164-70. PubMed ID: 12522557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
